Blocknomi
Key Takeaways Guggenheim upgraded Eli Lilly’s price target to $1,273 from $1,235 while reaffirming its Buy recommendation Shares currently hover near $1,189, reflecting a 51% gain over the trailing 12-month…
Related articles
-
Ethereum (ETH) Price Surges Past $1,800 as Institutional Money Flows Back In
Blocknomi Published 12.07.2026 10:33
-
Ripple Remedies Fight Gets Another SEC Filing As Final Penalty Debate Drags On
NewsBTC Published 10.07.2026 14:35
-
Solana (SOL) Must Conquer $85 Resistance to Reach $100 Target
Blocknomi Published 10.07.2026 07:09
-
Visa, Mastercard, And Over 140 Companies Launch Stablecoin Open USD
Bitcoin Magazine Published 30.06.2026 17:27
-
Metaplanet adds 2,823 bitcoin to holdings in Q2, bringing total to 43,000 BTC
The Block Published 02.07.2026 09:00
-
Institutional crypto exchange EDX lands $76M from SBI Holdings
Cointelegraph Published 07.07.2026 16:16
-
Irish authorities recover another 500 bitcoins from lost Clifton Collins drug stash
The Block Published 02.07.2026 17:30
-
Ethereum Staking Rate Surpasses 33% Despite Price Weakness
Blocknomi Published 01.07.2026 13:51